{"slideshow_credits": null, "snippet": "The company that will be spun off, to be called Zoetis, has about $4.2 billion in annual revenue and could be valued at $15 billion or more.", "abstract": "The company that will be spun off, to be called Zoetis, has about $4.2 billion in annual revenue and could be valued at $15 billion or more.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Dealbook", "role": "reported", "rank": 1, "organization": ""}], "original": "By DEALBOOK"}, "web_url": "http://dealbook.nytimes.com/2012/08/13/pfizer-animal-health-unit-files-for-i-p-o/", "lead_paragraph": null, "headline": {"main": "Pfizer Animal Health Unit Files for I.P.O.", "kicker": "DealBook"}, "_id": "502947cc1c22dfde670b5c8d", "word_count": "276", "multimedia": [], "pub_date": "2012-08-13T14:28:25Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Initial Public Offerings", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}